Causes and Symptoms of Vitamin B12 Deficiency

Vitamin B12 deficiency can lead to macrocytic anaemia and neurological symptoms. The most common cause of this deficiency is the presence of anti-intrinsic factor antibodies. Intrinsic factor is necessary for the absorption of dietary vitamin B12 in the terminal ileum. Without it, vitamin B12 cannot be absorbed, leading to deficiency and anaemia. Symptoms of vitamin B12 deficiency include fatigue, lethargy, dyspnoea on exertion, and neurological symptoms such as peripheral loss of vibration and proprioception, weakness, and paraesthesiae. If left untreated, it can lead to hepatosplenomegaly, heart failure, and demyelination of the spinal cord, causing ataxia.

Diagnosis can be made with a vitamin B12 level test, which reveals anaemia, often pancytopenia, and a raised MCV. A blood film reveals hypersegmented neutrophils, megaloblasts, and oval macrocytes. Treatment involves replacement of vitamin B12.

Other possible causes of vitamin B12 deficiency include intestinal tapeworm, which is rare, and gastrointestinal malignancy, which causes iron deficiency anaemia with a low MCV. Destruction of the anterior and lateral horns of the spinal cord describes anterolateral sclerosis (ALS), which is characterised by progressive muscle weakness and would not cause anaemia or loss of sensation. Enlargement of the ventricles on head CT indicates hydrocephalus, which could explain the wide-based gait but not the anaemia and other symptoms. A haemoglobin A1c of 12.2% is associated with diabetes, which could explain decreased peripheral sensation to fine touch but would not be associated with megaloblastic anaemia.

Specialty Departments and Diagnosis of Coeliac Disease

The patient presents with microcytic, hypochromic anaemia, Howell-Jolly bodies, and splenic dysfunction, along with low albumin and calcium suggestive of malabsorption and emaciation. The most likely diagnosis is coeliac disease, which can be confirmed by antibody tests and a duodenal biopsy in the Gastroenterology department. Haematology can investigate the abnormal blood count, but treatment is not within their scope. Chronic kidney or liver disease is less likely, and there are no neurological symptoms.

Autoimmune Disorders and Associated Antibodies

Autoimmune disorders occur when the immune system mistakenly attacks healthy cells and tissues in the body. These disorders are often associated with the presence of specific antibodies that can help diagnose and monitor the disease. Here are some examples:

Pernicious Anaemia and Anti-Intrinsic Factor Antibodies
Pernicious anaemia is a type of anaemia caused by a deficiency in vitamin B12. It is associated with the presence of anti-intrinsic factor antibodies, which bind to intrinsic factor and prevent the absorption of vitamin B12 in the gut.

Primary Biliary Cholangitis and Anti-Jo-1 Antibodies
Primary biliary cholangitis is an autoimmune disorder that affects the liver. It is associated with the presence of anti-mitochondrial antibodies, but not anti-Jo-1 antibodies, which are associated with other autoimmune disorders like polymyositis and dermatomyositis.

Myasthenia Gravis and Voltage-Gated Calcium Channel Antibodies
Myasthenia gravis is a neuromuscular disorder that causes muscle weakness and fatigue. It is associated with the presence of anti-acetylcholine receptor antibodies, but not anti-striated muscle antibodies, which are found in other autoimmune disorders.

Granulomatosis with Polyangiitis (GPA) and Anti-Myeloperoxidase (p-ANCA) Antibody
GPA is a type of vasculitis that affects small and medium-sized blood vessels. It is associated with the presence of cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA), but not p-ANCA, which are found in other types of vasculitis.

Hashimoto’s Thyroiditis and Thyroid-Stimulating Antibodies
Hashimoto’s thyroiditis is an autoimmune disorder that affects the thyroid gland. It is associated with the presence of anti-thyroglobulin and anti-thyroperoxidase antibodies, which attack the thyroid gland and cause inflammation.

Treatment options for ITP patients

Intravenous immunoglobulin is the preferred treatment for patients with immune thrombocytopenia (ITP) who also have diabetes. Steroids may be used as a trial treatment if the patient does not have any contraindications for steroid-related complications. Platelets are not typically effective in raising platelet counts in ITP patients because they are destroyed by the antibodies. However, they may be used in emergency situations to treat major bleeding. It is important for healthcare providers to carefully consider the individual patient’s medical history and current condition when selecting a treatment plan for ITP. Proper treatment can help manage symptoms and improve quality of life for patients with this condition.

AFP Measurement for Detecting Birth Defects and Chromosomal Abnormalities

When a woman is 15 weeks pregnant, a blood test called AFP measurement can be performed to determine if there is an increased risk of certain birth defects and chromosomal abnormalities. This test can detect open neural tube or abdominal wall defects, as well as Down’s syndrome and trisomy 18. In the past, if the results of the AFP measurement were abnormal, an ultrasound scan would be performed. However, it is possible that in the future, mid-trimester anomaly scanning may replace the use of AFP measurement altogether.

Hormone Levels and Menopausal Status

Follicle-stimulating hormone (FSH) levels that are greater than 30 IU/l, repeated over a period of four to eight weeks, are typically indicative of menopause. It is important to ensure that FSH is tested when the patient is not on contraception, although this is not relevant in the current scenario. While oestrogen and progesterone levels decrease after menopause, their assay is less reliable in determining menopausal status compared to FSH levels. Beta-HCG levels are elevated during pregnancy and trophoblastic disease, while prolactin levels increase in response to certain drug therapies and the presence of a pituitary tumour.

Blood Testing for Elective Surgeries

When it comes to elective surgeries, a group and save blood testing procedure is typically sufficient. This is a common practice in modern blood banks and involves determining the patient’s blood group and confirming it, as well as conducting an antibody screen. If the antibody screen test comes back positive, additional tests such as a cross match or direct Coombs’ test (also known as the direct antiglobulin test or DAT) may be necessary. However, these tests are not typically performed unless the patient has a recent history of blood transfusions or known red cell antibodies. Overall, the group and save method is a standard and effective way to ensure that patients have the appropriate blood type available in case of a transfusion during elective surgeries.

Probable Diagnosis of Acute Lymphoblastic Leukaemia in a Child

This child is likely to have acute lymphoblastic leukaemia (ALL) based on the presence of immature white cells on their full blood count (FBC). Hodgkin’s disease is unlikely as the patient is too young and typically presents with lymphadenopathy. HIV is also not a probable cause of the immature cells on the FBC.

Acute lymphoblastic leukaemia is a type of cancer that affects the white blood cells, specifically the lymphocytes. It is most commonly diagnosed in children and young adults. Symptoms may include fatigue, fever, and easy bruising or bleeding. Treatment typically involves chemotherapy and may also include radiation therapy or stem cell transplantation. Early diagnosis and treatment are important for improving outcomes in patients with ALL.

Preparation of Plasma Derivatives

The preparation of plasma derivatives, such as factor VIII, involves pooling several thousand plasma donations, typically 20,000 or 5,000 kg of plasma at a time. To avoid the risk of vCJD, pooled plasma has been sourced from outside the UK since 1999. The process includes several chemical steps, including ethanol extraction, chromatography, and viral inactivation, resulting in a freeze-dried product. These products have a long shelf life of several months to years.

Common Causes of Transfusion Errors

Mislabelling of samples, requests, or misidentifying recipients are the most frequent causes of transfusion errors. This was confirmed by the SHOT study, which examined transfusion errors and near-misses in a nationwide audit in the United Kingdom. Although other errors, such as cross-match errors, incorrect storage, and transfusion reactions due to undetected antibodies, do occur, they are infrequent.

In summary, the SHOT study found that the most common causes of transfusion errors are related to labelling and identification. Therefore, it is crucial to implement strict protocols and procedures to ensure that samples and requests are correctly labelled and recipients are accurately identified to prevent these errors from occurring. While other errors may occur, they are rare and can be mitigated through proper training and adherence to established guidelines.

Hereditary Haemorrhagic Telangiectasia

Hereditary haemorrhagic telangiectasia is a genetic disorder that causes bleeding from small blood vessels called telangiectasia on mucous membranes such as the nose, mouth, and gastrointestinal tract. This condition is characterised by the presence of telangiectasia on the skin, which can be seen during clinical examination. In some cases, arteriovenous malformations may also be present in the lung or brain.

Understanding Iron Deficiency Anaemia and Treatment Options

Iron deficiency anaemia is a common condition that can present with symptoms such as lethargy, tiredness, and shortness of breath on exertion. It is often seen in women due to menstruation and blood loss associated with it, as well as in pregnant women. However, it is not a common finding in men and should be investigated further if present.

Treatment for iron deficiency anaemia involves the use of ferrous sulfate, typically at a dose of 200 mg two to three times a day for at least three months. Blood tests should be repeated after this time to assess the effectiveness of therapy. Folic acid supplementation may also be necessary in cases of folate deficiency anaemia, which presents with a raised MCV.

It is important to investigate persistent anaemia despite adequate iron supplementation, as it may indicate an underlying malignancy. Men with unexplained iron deficiency anaemia and a haemoglobin level of < 110 g/l should be referred urgently to the gastroenterology team for investigation of upper or lower gastrointestinal malignancy. Overall, understanding the causes and treatment options for iron deficiency anaemia can help improve patient outcomes and prevent complications.

Polyarteritis nodosa (PAN) is a systemic disease that affects small or medium-sized arteries in various organs, leading to a wide range of symptoms such as nerve damage, skin issues, joint and muscle pain, kidney problems, and heart issues. Laboratory findings include anemia, increased white blood cells and platelets, and elevated inflammatory markers. ANCA testing can help differentiate PAN from other vasculitis diseases.

Microcytic Hypochromic Anaemia and the Importance of Blood Transfusion

This patient is presenting with a microcytic hypochromic anaemia, which is commonly caused by iron deficiency due to occult gastrointestinal (GI) blood loss in a Caucasian population. To determine the cause of the anaemia, a full history and examination should be conducted to look for clues of GI blood loss. Given the microcytic hypochromic picture, it is likely that blood loss has been ongoing for some time.

Although there is no evidence of haemodynamic compromise or congestive cardiac failure (CCF), the patient is experiencing breathlessness on minimal exertion. This justifies an upfront transfusion to prevent the patient from going into obvious cardiorespiratory failure. At a Hb of 64 g/L in a 72-year-old, the benefits of transfusion outweigh the risks.

While haematinics such as ferritin, vitamin B12, and folate are important investigations, the most crucial management step is organising a blood transfusion. This will help to address the immediate issue of anaemia and prevent further complications.

Comparison of DIC, von Willebrand’s Disease, Liver Failure, Haemophilia, and Heparin Administration

Disseminated intravascular coagulopathy (DIC) is a serious complication of severe sepsis that can lead to multiorgan failure and widespread bleeding. It is characterized by high prothrombin time and the use of fibrinogen for widespread clot formation, resulting in high levels of D-dimer due to intense fibrinolytic activity. DIC is a paradoxical state in which the patient is prone to clotting but also to bleeding.

Von Willebrand’s disease is an inherited disorder of coagulation that is usually autosomal dominant. There is insufficient information to suggest that the patient in this case has von Willebrand’s disease.

Liver failure could result in excessive bleeding due to disruption of liver synthetic function, but there is no other information to support liver failure in this case. Signs of hepatic encephalopathy or jaundice would also be expected.

Haemophilia is an X-linked recessive disorder of coagulation that is characterized by prolonged activated partial thromboplastin time (APTT) and normal prothrombin time.

There is no information to suggest that heparin has been administered, and the bleeding time and platelet count would be normal.

Delayed Grief Reaction and Elevated MCV in a Patient

Explanation:
The patient in question is displaying a delayed grief reaction following the recent death of her husband. Her FBC shows a normal picture except for an elevated MCV, which suggests alcohol excess. If the cause of macrocytosis were folate or B12 deficiency, it would be expected to cause anemia in association with the macrocytosis. Hypothyroidism may also cause macrocytosis, but the patient’s weight loss argues against this diagnosis. For further information on macrocytosis, refer to the BMJ Practice article Macrocytosis: pitfalls in testing and summary of guidance, the BMJ Endgames case report A woman with macrocytic anemia and confusion, and the BMJ Best Practice article Assessment of anemia.

Treatment Options for Hypernatraemia: A Case Study

Hypernatraemia is a condition characterized by an elevated sodium concentration in the blood. In this case study, the patient’s hypernatraemia is mild and caused by insufficient free water intake. It is important to rule out infection as a cause of hypernatraemia, which can increase free water loss. Mild calcification of the aortic arch is a common finding in the elderly and unrelated to the patient’s current complaint.

Hypertonic saline infusion is not recommended as it would further increase the sodium concentration. Standard dialysis is not necessary in this case as the hypernatraemia is not profound enough. 500 ml of 10% dextrose is not appropriate as it is not equivalent to giving free water and is used to reverse hypoglycaemia. 500 ml of 0.9% saline is not the correct option for this patient, but it may be appropriate for hypovolaemic and hypotensive patients to restore circulating volume.

The most appropriate treatment option for this patient is to provide free water, which can be achieved by administering 5% dextrose. It is important to monitor the patient’s sodium levels and fluid intake to prevent further complications. The decision to start hypertonic saline infusion or dialysis should be made by a consultant in severe cases of hypernatraemia.

Diagnosis and Treatment of Deep Vein Thrombosis

This patient is showing typical symptoms of a deep vein thrombosis (DVT). While you may not have access to the necessary investigations in your practice, it is important to have knowledge of secondary care investigations and their appropriate use, as highlighted in the latest MRCGP curriculum statement. Venous Dopplers are the most likely test to confirm the diagnosis, while a venogram is considered the gold standard.

DVTs should be treated with anticoagulation, typically with the use of DOACs due to the potential risk of embolisation. It is important to promptly diagnose and treat DVTs to prevent complications such as pulmonary embolism. As a healthcare professional, it is important to stay up-to-date with the latest guidelines and recommendations for the diagnosis and treatment of DVTs.

Smouldering myeloma is a stage between monoclonal gammopathy of unknown significance (MGUS) and myeloma. To diagnose this condition, the patient must have a monoclonal protein in the serum of at least 30 g/l and monoclonal plasma cells of at least 10% in bone marrow or tissue biopsy, but no evidence of end-organ damage. Patients with smouldering myeloma should be closely monitored as they are at high risk of developing symptomatic myeloma.

Multiple myeloma is a malignant neoplasm where there is clonal proliferation of plasma cells in the bone marrow, leading to the secretion of a monoclonal antibody and light immunoglobulin chains that cause organ damage. Patients with multiple myeloma present with various symptoms, including lethargy, bone pain, pathological fractures, renal impairment, amyloidosis, and pancytopenia due to marrow infiltration. To diagnose multiple myeloma, the patient must have a monoclonal antibody in serum and/or urine, clonal plasma cells of at least 10% on bone marrow biopsy, and evidence of end-organ damage.

MGUS is a condition where low levels of paraprotein are detected in the blood, but they are not causing clinically significant symptoms or end-organ damage. To diagnose MGUS, the patient must have a monoclonal protein in the serum of less than or equal to 30 g/l, monoclonal plasma cells of less than or equal to 10% in bone marrow or tissue biopsy, and no evidence of end-organ damage.

Non-secretory myeloma is a rare variant of multiple myeloma where the bone marrow findings and end-organ damage are similar to myeloma, but there is no detectable monoclonal protein in the serum or urine. This makes it difficult to diagnose.

Plasma cell leukemia is a rare and aggressive form of multiple myeloma characterized by high levels of plasma cells circulating in the peripheral blood. It can occur as a primary condition or a secondary leukaemic transformation of multiple myeloma.

Follicular lymphoma is a prevalent type of non-Hodgkin’s lymphoma that results from a chromosomal translocation between chromosome 14 and chromosome 18. This translocation causes the bcl-2 protein, which is anti-apoptotic, to be moved to the IgH promoter region, leading to overproduction of bcl-2. Consequently, abnormal B cells undergo clonal proliferation and are protected from apoptosis. Follicular lymphoma affects both genders equally, and its incidence increases with age. The disease typically presents with painless adenopathy that progresses over time. Systemic symptoms, such as fevers, night sweats, and weight loss, may occur later in the disease progression and can be associated with anaemia, thrombocytopenia, and lymphocytosis. Diagnosis requires a lymph node biopsy to demonstrate the expansion of follicles filling the node and chromosomal analysis of cells from bone marrow aspiration to detect t(14:18). Chemotherapy is the primary treatment, and rituximab, a monoclonal antibody against the CD20 protein found on B cells, is often used in combination with other agents. In Burkitt’s lymphoma, c-myc overexpression is caused by a translocation between chromosomes 8 and 14, while chronic myeloid leukaemia results from a translocation between chromosomes 9 and 22, forming the Philadelphia chromosome. Ewing’s sarcoma is caused by a translocation between chromosomes 11 and 12, leading to the formation of the fusion protein Ewsr1-fli1, which causes aberrant transcription of genes regulating cell growth and development. In a small subset of follicular lymphoma patients, translocations involving the bcl-6 gene and protein are found, which may increase the risk of transformation to a more aggressive form.

Factor V Leiden: A Genetic Condition Affecting Blood Clotting

Factor V is a protein that acts as a cofactor to allow the generation of an enzyme called thrombin, which is responsible for cleaving fibrinogen to fibrin. This process leads to the formation of a dense meshwork that makes up the majority of a clot. Activated protein C (aPC) is a natural anticoagulant that limits clotting by degrading factor V. However, in individuals with Factor V Leiden, a genetic condition that is inherited in an autosomal dominant manner, the coagulation factor cannot be destroyed by aPC.

Factor V Leiden is caused by a single nucleotide substitution of adenine for guanine in the gene encoding factor V. This mutation changes the protein’s 506th amino acid from arginine to glutamine, which prevents efficient inactivation of factor V. As a result, factor V remains active, leading to overproduction of thrombin and excess fibrin generation, which in turn causes excess clotting.

In summary, Factor V Leiden is a genetic condition that affects blood clotting by preventing the efficient inactivation of factor V. This leads to excess clotting, which can increase the risk of developing blood clots and related complications.

Understanding Anaemia of Chronic Disease: Increased Ferritin and Decreased TIBC

Anaemia of chronic disease is a type of anaemia that is commonly seen in patients with chronic inflammatory conditions. It is characterised by a low haemoglobin level and low haematocrit, but unlike iron deficiency anaemia, it is associated with increased ferritin levels and decreased total iron-binding capacity (TIBC). This is because ferritin is a serum reactive protein that is elevated in response to the underlying inflammatory process.

Diagnosis of anaemia of chronic disease requires the presence of a chronic inflammatory condition and anaemia, which can be either normocytic or microcytic. It is important to note that a haemoglobin level of <80 g/l is very rarely associated with this type of anaemia. Treatment involves addressing the underlying disorder causing the anaemia and monitoring the haemoglobin level. Blood transfusion is only used in severe cases. It is important to differentiate anaemia of chronic disease from other types of anaemia. For example, it is characterised by a low reticulocyte count, and not reticulocytosis. Serum transferrin receptor is not affected in anaemia of chronic disease and would therefore be normal. Additionally, TIBC is reduced in anaemia of chronic disease, whereas it is increased in iron deficiency anaemia. Finally, anaemia of chronic disease is associated with either microcytosis or normocytosis, whereas macrocytosis is associated with other types of anaemia such as folate deficiency, vitamin B12 deficiency, alcohol excess, and myelodysplastic disease. In summary, understanding the unique features of anaemia of chronic disease, such as increased ferritin and decreased TIBC, can aid in its diagnosis and management.

The Role of Hormone Assays in Confirming Pregnancy

Beta-HCG is a hormone produced by the placenta during pregnancy. There are highly sensitive assays available to detect the presence of beta-HCG, which can confirm pregnancy. In fact, some manufacturers of pregnancy tests claim that their tests are more accurate than ultrasound dating in determining gestation during the early stages of pregnancy.

While alpha-fetoprotein may also be elevated in pregnancy, particularly in cases of neural tube defects, it is not the primary focus of pregnancy testing. Hormone assays for oestrogen, progesterone, or testosterone levels are not reliable methods for confirming pregnancy. Therefore, beta-HCG remains the most reliable hormone to test for when confirming pregnancy.

It is important to note that while hormone assays can confirm pregnancy, they cannot determine the viability of the pregnancy or the presence of any complications. Ultrasound imaging and other diagnostic tests may be necessary to assess the health of the pregnancy and the developing fetus.

Different types of lipoproteins carry lipids and cholesterol throughout the body. Chylomicrons transport dietary lipids, VLDLs transport liver-synthesized lipids, LDLs carry cholesterol, and HDLs transport cholesterol back to the liver for breakdown. Fatty acids are broken down by pancreatic lipase and absorbed as free fatty acids and monoglycerides, which are then reformed into triglycerides and packaged into chylomicrons. The liver processes chylomicron remnants and liposomes into various lipoprotein forms, including VLDL and LDL. Apolipoproteins are proteins that bind to lipids to form lipoproteins. HDL particles remove cholesterol from circulation and transport it back to the liver. Oxidized LDL is harmful to the body and promotes atherosclerosis.

Treatment Options for Non-Haemolytic Febrile Transfusion Reaction

Non-haemolytic febrile transfusion reaction is a common acute reaction to plasma proteins during blood transfusions. If a patient experiences this reaction, the transfusion should be temporarily stopped, and clerical checks should be repeated. The patient should be treated with paracetamol, and observations should be repeated more regularly (every 15 minutes).

If the patient’s temperature is less than 38.5 degrees, and they are asymptomatic with normal observations, the transfusion can be continued with more frequent observations and paracetamol. However, if the patient experiences transfusion-associated circulatory overload, furosemide is a suitable treatment option.

Adrenaline is not needed unless there are signs of anaphylaxis, and antihistamines are only suitable for urticaria during blood transfusions. Therefore, it is essential to identify the specific type of transfusion reaction and provide appropriate treatment accordingly.

Leukapheresis and Other Treatment Options for Chronic Myeloid Leukaemia with High White Blood Cell Count and Ischaemic Stroke

Chronic myeloid leukaemia can cause an extremely high white blood cell count, leading to hyperviscosity of the blood and an increased risk of ischaemic events such as stroke. While anticoagulation medications are important, they do not address the underlying issue of the high cell count. Leukapheresis is a procedure that can reduce the white cell volume by 30-60%, making it a crucial emergency treatment option. Other treatments, such as hydroxyurea and imatinib, can also be used to control disease burden. Imatinib is a tyrosine kinase inhibitor that is effective in treating chronic myeloid leukaemia with the Philadelphia chromosome translocation. Aspirin and heparin have limited roles in this scenario. While aspirin is recommended for long-term therapy after an ischaemic stroke, it does not address the hypercoagulable state caused by the high white blood cell count. Heparin is not used in the treatment of ischaemic strokes. Overall, leukapheresis should be the first step in emergency management for chronic myeloid leukaemia with a high white blood cell count and ischaemic stroke.

Complications of Blood Transfusions: Understanding the Risks

Blood transfusions are a common medical intervention used to treat a variety of conditions, from severe bleeding to anaemia. While they can be life-saving, they also carry certain risks and potential complications. Here are some of the most common complications associated with blood transfusions:

Transfusion haemosiderosis: Repeated blood transfusions can lead to the accumulation of iron in the body’s organs, particularly the heart and endocrine system. This can cause irreversible heart failure if left untreated.

High-output cardiac failure: While anaemia on its own may not be enough to cause heart failure, it can exacerbate the condition in those with reduced left ventricular systolic dysfunction.

Acute haemolytic transfusion reaction: This occurs when there is a mismatch between the major histocompatibility antigens on blood cells, such as the ABO system. It can cause severe intravascular haemolysis, disseminated intravascular coagulation, renal failure, and shock, and has a high mortality rate if not recognized and treated quickly.

Pulmonary oedema: While rare in patients with normal left ventricular systolic function, blood transfusions can cause fluid overload and pulmonary oedema, which can exacerbate chronic heart failure.

Transfusion-related bacterial endocarditis: While rare, bacterial infections can occur from blood transfusions. Platelet pools, which are stored at room temperature, have a slightly higher risk of bacterial contamination that can cause fulminant sepsis.

Understanding the potential complications of blood transfusions is important for both patients and healthcare providers. By recognizing and addressing these risks, we can ensure that blood transfusions remain a safe and effective treatment option for those who need them.

Pathophysiological Mechanisms of Various Medical Conditions

Haemophilia: Deficiency of a Clotting Factor in the Intrinsic Pathway of Coagulation
Haemophilia is an X-linked recessive condition that affects the intrinsic pathway of coagulation. It is caused by a mutation in factor VIII or IX, leading to deficient coagulation. Patients present with excessive bleeding, such as spontaneous bruising, prolonged bleeding following a dental procedure or minor injury, bleeding into the joints (haemarthrosis), and epistaxis. Treatment involves correcting the deficiency with concentrated factor VIII or IX.

Von Willebrand’s Disease: Deficiency of a Protein Found in Endothelial Cells and Released by Endothelial Damage
Von Willebrand’s disease is an autosomal dominant, inherited bleeding disorder caused by a deficiency of the von Willebrand factor. This protein is found in the endothelial cells lining the vessels and is released following endothelial damage. It promotes adhesion of platelets to the area of damage and stabilizes factor VIII, both actions promoting haemostasis. Symptoms include easy bruising and prolonged bleeding following minimal trauma.

Ewing’s Sarcoma: Translocation Between Chromosomes 11 and 22
Ewing’s sarcoma is a malignant bone tumour seen in children and young adults. It is caused by a translocation between chromosomes 11 and 22.

Leukaemia: Invasion of Bone Marrow by Leukaemic Cells
Leukaemia is a type of cancer that affects the blood and bone marrow. It is caused by the invasion of bone marrow by leukaemic cells, leading to pancytopenia, a condition in which there is a deficiency of all three types of blood cells: red blood cells, white blood cells, and platelets. Symptoms include fatigue, weakness, shortness of breath, and increased susceptibility to infections. Treatment involves chemotherapy, radiation therapy, and bone marrow transplantation.

Managing DIC in a Patient with Septic Shock: Evaluating Treatment Options

When managing a patient with disseminated intravascular coagulation (DIC), it is important to consider the underlying condition causing the DIC. In the case of a patient with septic shock secondary to a urinary tract infection, the sepsis 6 protocol should be initiated alongside pre-emptive management for potential blood loss.

While a blood cross-match is sensible, emergency blood products such as platelets are unwarranted in the absence of acute bleeding. Activated protein C, previously recommended for DIC management, has been removed from guidelines due to increased bleeding risk without overall mortality benefit.

Anticoagulation with low molecular weight heparin is unnecessary at this time, especially when given with blood products, which are pro-coagulant. Tranexamic acid and platelet transfusions are only warranted in the presence of severe active bleeding.

Prophylactic dose unfractionated heparin may be a good management strategy in the presence of both thrombotic complications and increased bleeding risk, but should be given at a treatment dose if deemed necessary. Ultimately, managing the underlying septic shock is the best way to manage DIC in this patient.

Understanding Aplastic Crisis and Sickle-Cell Disease

Aplastic crisis is a condition of transient bone marrow failure that can be precipitated by parvovirus B19, Epstein–Barr virus (EBV), or Streptococcus. In sickle-cell disease, aplastic crisis is usually caused by parvovirus B19 and is characterized by reticulocytopenia, symptomatic anemia, and the presence of parvovirus immunoglobulin M (IgM) antibodies. It is managed by monitoring and symptomatic relief with blood transfusion until normal erythrocyte function returns. Aplastic crisis is most common in individuals of Mediterranean descent.

Sickle-cell disease is most common in individuals of Black Afro-Caribbean descent and, to a lesser extent, in individuals of Mediterranean or Middle Eastern descent. It occurs as a result of the production of an abnormal beta (β) chain in haemoglobin, caused by a mutation that changes adenine to thymine in the sixth codon of the β chain gene. This results in the formation of HbS, which circulates in the blood and forms polymers in the deoxygenated state, causing sickling of red blood cells. The resulting blood film shows elongated, thin, sickled red blood cells, target cells, and Howell–Jolly bodies.

Splenomegaly is most usually seen in childhood, as most children with sickle-cell disease have a splenic infarction event in late childhood and develop hyposplenism. Spherocytes, on the other hand, are abnormal red blood cells with a spherical shape, seen on the blood film of spherocytosis, a form of haemolytic anaemia.